The results were the same whether patients were enrolled earlier or later after return of circulation, the LOGICAL ...
James O’Mahoney says what came after his treatment inspired a new perspective on living well for as long as possible ...
A systematic review and meta-analysis of 8 observational studies found that greater obstructive sleep apnea severity was ...
EMSense is a foot massager designed to help relieve foot pain, numbness, tingling, and swelling through a combination of heat ...
Pharmaceutical Technology on MSN
FDA widens Vertex’s Casgevy use for paediatric patients
Children as young as two with either sickle cell disease or thalassemia are now eligible for the gene therapy.
State-of-the-art gene therapy provides new treatment option for children 2 years and older with life-threatening blood disorder ...
We tested top wearables and pads, including NovaaLab, Kineon, and Mito Red Light, to help you find the right fit for your recovery routine.
Blind People Offered Hope of Seeing Again After Stem Cell Breakthrough Remakes Retinal Blood Vessels
When injected into mice with retinal disease, the special retinal blood cells integrated into the damaged tissue to ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the U.S. Food and Drug Administration (FDA) has approved expanded use of CASGEVY ® (exagamglogene autotemcel) for the treatment ...
Ann Temple walks up the steps of her Mitchell home just because she can. "I bet I do it 10 times a day, and it's just like walking on level ground," she said, glancing over at the ...
Longevity is plastered across social media and wellness menus to the point where it's practically lost its meaning. After all, isn't the secret to living a long and healthy life down to the simple ...
Vertex Pharmaceuticals and CRISPR Therapeutics' gene-editing drug is the only sickle cell disease gene therapy on the market for young children.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results